The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
‘Spice’ and other herbal blends: harmless incense or cannabinoid designer drugs?
Abstract
Journal of Mass SpectrometryVolume 44, Issue 5 p. 832-837 JMS Letter 'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs? Volker Auwärter, Corresponding Author Volker Auwärter volker.auwaerter@uniklinik-freiburg.de Institute of Forensic Medicine, Forensic Toxicology, University Medical Centre Freiburg, Albertstr. 9, 79104 Freiburg, GermanyInstitute of Forensic Medicine, Forensic Toxicology, University Medical Centre Freiburg, Albertstr. 9, 79104 Freiburg, Germany.===Search for more papers by this authorSebastian Dresen, Sebastian Dresen Institute of Forensic Medicine, Forensic Toxicology, University Medical Centre Freiburg, Albertstr. 9, 79104 Freiburg, GermanySearch for more papers by this authorWolfgang Weinmann, Wolfgang Weinmann Institute of Forensic Medicine, Forensic Toxicology, University Medical Centre Freiburg, Albertstr. 9, 79104 Freiburg, GermanySearch for more papers by this authorMichael Müller, Michael Müller Institute of Pharmaceutical Sciences, Albert-Ludwigs-University Freiburg, Albertstr. 25, 79104 Freiburg, GermanySearch for more papers by this authorMichael Pütz, Michael Pütz Bundeskriminalamt, Federal Criminal Police Office, Forensic Science Institute, KT34-Toxicology, 65173 Wiesbaden, GermanySearch for more papers by this authorNerea Ferreirós, Nerea Ferreirós Institute of Forensic Medicine, Forensic Toxicology, University Medical Centre Freiburg, Albertstr. 9, 79104 Freiburg, GermanySearch for more papers by this author Volker Auwärter, Corresponding Author Volker Auwärter volker.auwaerter@uniklinik-freiburg.de Institute of Forensic Medicine, Forensic Toxicology, University Medical Centre Freiburg, Albertstr. 9, 79104 Freiburg, GermanyInstitute of Forensic Medicine, Forensic Toxicology, University Medical Centre Freiburg, Albertstr. 9, 79104 Freiburg, Germany.===Search for more papers by this authorSebastian Dresen, Sebastian Dresen Institute of Forensic Medicine, Forensic Toxicology, University Medical Centre Freiburg, Albertstr. 9, 79104 Freiburg, GermanySearch for more papers by this authorWolfgang Weinmann, Wolfgang Weinmann Institute of Forensic Medicine, Forensic Toxicology, University Medical Centre Freiburg, Albertstr. 9, 79104 Freiburg, GermanySearch for more papers by this authorMichael Müller, Michael Müller Institute of Pharmaceutical Sciences, Albert-Ludwigs-University Freiburg, Albertstr. 25, 79104 Freiburg, GermanySearch for more papers by this authorMichael Pütz, Michael Pütz Bundeskriminalamt, Federal Criminal Police Office, Forensic Science Institute, KT34-Toxicology, 65173 Wiesbaden, GermanySearch for more papers by this authorNerea Ferreirós, Nerea Ferreirós Institute of Forensic Medicine, Forensic Toxicology, University Medical Centre Freiburg, Albertstr. 9, 79104 Freiburg, GermanySearch for more papers by this author First published: 02 February 2009 https://doi.org/10.1002/jms.1558Citations: 490Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Citing Literature Volume44, Issue5May 2009Pages 832-837 RelatedInformation
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Huffman, J. W., Zengin, G., Wu, M.-J., Lu, J., Hynd, G., Bushell, K., Thompson, A. L. S., Bushell, S., Tartal, C., Hurst, D. P., et al. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.09.050 · Cited by 259
Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB1 and CB2 receptor binding
Aung, M. M., Griffin, G., Huffman, J. W., Wu, M.-J., Keel, C., Yang, B., Showalter, V. M., Abood, M. E., & Martin, B. R. (2000) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(99)00152-0 · Cited by 254
Compton, D. R., Johnson, M. R., Melvin, L. S., & Martin, B. R. (1992) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11216-0 · Cited by 215
Melvin, L. S., Milne, G. M., Johnson, M. R., Subramaniam, B., Wilken, G. H., & Howlett, A. C. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13256-2 · Cited by 136
Cannabimimetic activity from CP-47,497, a derivative of 3-phenylcyclohexanol.
Weissman, A., Milne, G. M., & Melvin, L. S. (1982) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)33364-1 · Cited by 107
A cannabinoid derived prototypical analgesic
Melvin, L. S., Johnson, M. R., Harbert, C. A., Milne, G. M., & Weissman, A. (1984) · Journal of Medicinal Chemistry · doi:10.1021/jm00367a013 · Cited by 97
CB1 Cannabinoid Receptor Ligands
Thakur, G. A., Nikas, S. P., & Makriyannis, A. (2005) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557054368772 · Cited by 90
Enhancement of brain [3H]flunitrazepam binding and analgesic activity of synthetic cannabimimetics
Koe, B. K., Milne, G. M., Weissman, A., Johnson, M. R., & Melvin, L. S. (1985) · European Journal of Pharmacology · doi:10.1016/0014-2999(85)90421-2 · Cited by 44
Cited by
Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications
Castaneto, M. S., Gorelick, D. A., Desrosiers, N. A., Hartman, R. L., Pirard, S., & Huestis, M. A. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.08.005 · Cited by 709
Hermanns‐Clausen, M., Kneisel, S., Szabo, B., & Auwärter, V. (2013) · Addiction · doi:10.1111/j.1360-0443.2012.04078.x · Cited by 479
Self-citationSeely, K. A., Lapoint, J., Moran, J. H., & Fattore, L. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.04.017 · Cited by 465
Beyond THC: The New Generation of Cannabinoid Designer Drugs
Fattore, L., & Fratta, W. (2011) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2011.00060 · Cited by 443
Tait, R. J., Caldicott, D., Mountain, D., Hill, S. L., & Lenton, S. (2016) · Clinical Toxicology · doi:10.3109/15563650.2015.1110590 · Cited by 378
Rosenbaum, C. D., Carreiro, S. P., & Babu, K. M. (2012) · Journal of Medical Toxicology · doi:10.1007/s13181-011-0202-2 · Cited by 355
Spice drugs as a new trend: Mode of action, identification and legislation
Vardakou, I., Pistos, C., & Spiliopoulou, C. (2010) · Toxicology Letters · doi:10.1016/j.toxlet.2010.06.002 · Cited by 341
“Zombie” Outbreak Caused by the Synthetic Cannabinoid AMB-FUBINACA in New York
Adams, A. J., Banister, S. D., Irizarry, L., Trecki, J., Schwartz, M., & Gerona, R. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1610300 · Cited by 320
Gone to Pot – A Review of the Association between Cannabis and Psychosis
Radhakrishnan, R., Wilkinson, S. T., & D’Souza, D. C. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00054 · Cited by 310
Dresen, S., Ferreirós, N., Pütz, M., Westphal, F., Zimmermann, R., & Auwärter, V. (2010) · Journal of Mass Spectrometry · doi:10.1002/jms.1811 · Cited by 309
Self-citationLindigkeit, R., Boehme, A., Eiserloh, I., Luebbecke, M., Wiggermann, M., Ernst, L., & Beuerle, T. (2009) · Forensic Science International · doi:10.1016/j.forsciint.2009.06.008 · Cited by 299
Synthetic cannabinoid JWH-018 and psychosis: An explorative study
Every-Palmer, S. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.01.012 · Cited by 299
Spicing things up: synthetic cannabinoids
Spaderna, M., Addy, P. H., & D’Souza, D. C. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3188-4 · Cited by 296
A survey study to characterize use of Spice products (synthetic cannabinoids)
Vandrey, R., Dunn, K. E., Fry, J. A., & Girling, E. R. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.07.011 · Cited by 283
Withdrawal Phenomena and Dependence Syndrome After the Consumption of „Spice Gold“
Zimmermann, U. S., Winkelmann, P. R., Pilhatsch, M., Nees, J. A., Spanagel, R., & Schulz, K. (2009) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2009.0464 · Cited by 278
Myocardial Infarction Associated With Use of the Synthetic Cannabinoid K2
Mir, A., Obafemi, A., Young, A., & Kane, C. (2011) · Pediatrics · doi:10.1542/peds.2010-3823 · Cited by 266
Atwood, B. K., Huffman, J., Straiker, A., & Mackie, K. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00582.x · Cited by 262
Adverse Effects of Synthetic Cannabinoids: Management of Acute Toxicity and Withdrawal
Cooper, Z. D. (2016) · Current Psychiatry Reports · doi:10.1007/s11920-016-0694-1 · Cited by 253
The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects
van Amsterdam, J., Brunt, T., & van den Brink, W. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114565142 · Cited by 244
Spanagel, R. (2020) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2020.22.3/rspanagel · Cited by 127
Novel halogenated derivates of JWH-018: behavioral and binding studies in mice
Vigolo, A., Ossato, A., Trapella, C., Vincenzi, F., Rimondo, C., Seri, C., Varani, K., Serpelloni, G., & Marti, M. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.02.008 · Cited by 91
Barbieri, M., Ossato, A., Canazza, I., Trapella, C., Borelli, A. C., Beggiato, S., Rimondo, C., Serpelloni, G., Ferraro, L., & Marti, M. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.06.027 · Cited by 56
Activity-based detection of synthetic cannabinoid receptor agonists in plant materials
Timmerman, A., Balcaen, M., Coopman, V., Degreef, M., Pottie, E., & Stove, C. P. (2024) · Harm Reduction Journal · doi:10.1186/s12954-024-01044-4 · Cited by 8
Metadata
- Authors
- Auwärter, V., Dresen, S., Weinmann, W., Müller, M., Pütz, M., & Ferreirós, N.
- Venue
- Journal of Mass Spectrometry
- Publisher
- Wiley
- Published
- 2009-02-02
- Volume
- 44
- Issue
- 5
- Pages
- 832-837
- ISSN
- 1076-5174 (ISSN-L)
- 1096-9888
- OpenAlex
- W2024053795
- Cited by
- 660
- References
- 8
- FWCI
- 69.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.